Take Solutions Ltd (TAKE) — shareholding pattern, promoter holding, financials and share price
About Take Solutions Ltd (TAKE)
Take Solutions Ltd operates in the Healthcare Research, Analytics & Technology industry, within the Healthcare sector. It trades on the NSE as TAKE and on the BSE under scrip code 532890. Its ISIN is INE142I01023.
Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services [1]
Take Solutions Limited is primarily focused on delivering domain-intensive services in Life Sciences, Software, and Information Technology, providing clinical, regulatory, and safety services for clients, including biopharmaceutical and generics manufacturers.
The company leveraged its technology expertise to launch OneClinical, an eClinical platform that optimizes clinical trials by providing real-time data analytics and visualization, enhancing compliance and operational efficiency across industry verticals.
Listed peers in Healthcare Research, Analytics & Technology: Bilcare Ltd, Jeevan Scientific Technology Ltd, Globalspace Technologies Ltd, Novelix Pharmaceuticals Ltd, Adeshwar Meditex Ltd, Vanta Bioscience Ltd.
Valuation & Returns
10 Jul 2026At ₹22.7 a share on 10 Jul 2026, Take Solutions Ltd (TAKE) was valued at a price-to-earnings ratio of 85.45x and a price-to-book of 16.36x on a book value of ₹1.39 per share as of Mar 2025. Solomo computes return on equity of 19.15% and return on capital employed of 21.63% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 85.45x
- P/B
- 16.36x
- EPS (TTM)
- ₹0.27
- Book value / share
- ₹1.39
- ROE
- 19.15%
- ROCE
- 21.63%
- ROA
- 10.77%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- 20.98%
- 52-week range
- ₹8.83 – ₹49.9
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Take Solutions Ltd (TAKE) reported revenue of ₹54 crore, net profit of ₹11 crore and earnings per share of ₹0.73. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹54.19 crore and net profit ₹4.36 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 655 | 189 | 4 | 0 | 54 |
| Net profit (₹ cr) | -782 | -100 | -120 | 37 | 11 |
| EPS (₹) | -52.88 | -6.78 | -8.09 | 2.53 | 0.73 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -30.44% | -18.28% | -63.17% | -100.00% |
| Profit growth | -6.32% | 5.54% | - | 131.32% |
| Stock price CAGR | -19% | -21% | 3% | 109% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 0% of Take Solutions Ltd (TAKE) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.21%. Market capitalisation was ₹336 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2010.
Largest disclosed public shareholders in Jun 2026: LLP 47.62%, Akarshika Traders 10.56%, Whamia Traders LLP 7.11%, Rukhmani Garments LLP 5.65%, Moonlight Multitrade LLP 5.59%, Avance Ventures Private Limited 5.48%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 0% | - | 0.21% | - | 100% |
| Mar 2026 | 0% | - | 0.29% | - | 100% |
| Dec 2025 | 0% | - | 0.56% | 0% | 100% |
| Sep 2025 | 5.19% | - | - | - | 94.81% |
| Jun 2025 | 53.34% | - | - | - | 46.66% |
| Mar 2025 | 53.41% | - | - | 0.01% | 46.59% |
| Dec 2024 | 53.41% | - | - | - | 46.59% |
| Sep 2024 | 53.41% | - | - | - | 46.59% |